Exogenus Therapeutics

Developing multifactorial, disease modifying biologics with wide potential application in regenerative medicine indications, including osteoarthritis

Exogenus Therapeutics leads a €13 million EU-funded consortium to advance a new secretome-based therapy for osteoarthritis

Collaborative R&D

Unlock Innovation Through Collaborative R&D

Together, we can accelerate development, share expertise, and create the technologies of the future.

Pipeline

Explore the progress of our innovations, from discovery to clinical development

Our Team

Get to Know the Faces behind Exogenus Therapeutics

IP & Publications

Science First!

We believe that impactful discoveries should be open and transparent.

latest news

Exogenus Therapeutics leads a €13 million EU-funded consortium to advance a new secretome-based therapy for osteoarthritis

ExoCordOA, a five-year project, led by Exogenus Therapeutics and backed by Horizon Europe, brings together ten organisations spanning biotechnology, clinical development, regulation, GMP manufacturing, imaging, academia and healthcare Consortium will advance EXO-101 towards clinical validation as a potential disease-modifying treatment for osteoarthritis Programme also aims to address scientific, manufacturing, quality-control and regulatory barriers across the extracellular vesicle and secretome therapeutics field Cantanhede, Portugal, 29 October – The ExoCordOA consortium today announced the launch of a five-year, €13 million project, funded by Horizon Europe to advance extracellular vesicle-enriched secretome therapies towards clinical use, with an initial focus on osteoarthritis.Led by Exogenus Therapeutics, ExoCordOA brings together ten organisations with complementary expertise across biotechnology, clinical and regulatory development, GMP manufacturing, medical imaging, academia and healthcare. The consortium will combine these capabilities to support the development of a new secretome-based medicine for osteoarthritis and help build the foundations for Europe’s leadership in secretome-based therapeutics.A central objective is to advance Exogenus’ lead candidate, EXO-101, towards clinical validation as a potential disease-modifying treatment for osteoarthritis. The programme will support the candidate’s Phase I and II clinical development while also addressing key scientific, manufacturing, quality-control and regulatory challenges that currently limit the clinical translation of extracellular vesicle...

Read More...
Exogenus Therapeutics LOGO

We´re hiring Computational Biology & AI Solutions Specialist

ABOUT EXOGENUS THERAPEUTICS Exogenus Therapeutics is a biotechnology company developing multifactorial, disease-modifying biologics for regenerative medicine. Our lead programme, Exo-101, is an extracellular-vesicle-enriched secretome in development for knee osteoarthritis. We are also exploring applications in cisplatin-induced hearing loss and other regenerative medicine indications. We combine scientific rigour, collaboration and responsible innovation to advance new therapies for patients.    ABOUT THE ROLE We are looking for a Computational Biology & AI Solutions Specialist to help translate scientific and business needs into practical, responsible and scalable data and AI solutions. Working across R&D and business development, you will combine hands-on bioinformatics with the evaluation, implementation and adoption of AI-enabled tools for data analysis, knowledge management and competitive intelligence. This role is well suited to someone who enjoys working with complex biological datasets, applying emerging technologies to research challenges and collaborating across scientific disciplines. WHAT YOU WILL DO Computational Biology and Bioinformatics: Develop and maintain pipelines for transcriptomic, proteomic and other omics data analyses. Integrate and analyse datasets from multi-omics experiments. Establish appropriate standards for data quality, documentation, version control and reproducibility. Translate analytical results into clear outputs for multidisciplinary R&D teams. AI solutions and cross-functional enablement: Identify and implement AI-based tools and...

Read More...
Exogenus Therapeutics LOGO

We´re hiring Scientist – Bioassays

ABOUT EXOGENUS THERAPEUTICS Exogenus Therapeutics is a biotechnology company developing multifactorial, disease-modifying biologics for regenerative medicine. Our lead programme, Exo-101, is an extracellular-vesicle-enriched secretome in development for knee osteoarthritis. We are also exploring applications in cisplatin-induced hearing loss and other regenerative medicine indications. We combine scientific rigour, collaboration and responsible innovation to advance new therapies for patients.  ABOUT THE ROLE We are looking for a Scientist with hands-on experience in cell-based bioassays to join our R&D team in Cantanhede. You will develop and run bioassays, contribute to experimental design and data interpretation, and support the introduction of robust workflows for research and quality-control applications. This role is well suited to someone who enjoys practical laboratory work, careful documentation and collaboration across scientific disciplines. WHAT YOU WILL DO Develop, optimise and implement cell-based and biomolecular in vitro bioassays and associated workflows. Plan and carry out experiments, analyse data and contribute to evidence-based technical decisions. Perform routine laboratory testing in accordance with approved protocols and quality requirements. Produce clear, accurate and traceable experimental records, reports and presentations. Contribute to assay transfer and quality-control activities in GMP-aligned or QMS environments. Support laboratory operations, including consumables planning, inventory and purchasing. Review relevant scientific literature...

Read More...

CENTRO2030-FSE+-0122970

CENTRO2030-FEDER-01680300

Co-financed by:

ExoTalent